| |
|
|
|
Matinas BioPharma Holdings Inc.  
|
|
0.6678 -0.006 (-0.01%) |
08-23 16:00 |
|
Open: |
0.69 |
Pre close: |
0.6735 |
Target:
|
0.89
|
|
High: |
0.69 |
Low: |
0.65 |
Resistance:
|
0.76
0.85
|
|
Volume: |
265,157 |
Market Cap: |
108M |
Support:
|
0.62
0.52
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.68
 |
MACD |
MACD(12,26):
|
-0.03  |
|
MA(20): |
0.72 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
0.88 |
Stochastic Oscillator |
%K(14,3):
|
29.28 |
|
MA(250): |
0.87 |
%D(3): |
25.96 |
|
Average Volume(K) |
3-Month: |
65638
|
52-Week |
High:
|
1.50 |
|
10-Days: |
71616 |
Low: |
0.37 |
|
RSI |
RSI(14):
|
38.51 |
Change(%): |
71.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.132 |
Return on Equity (ttm) |
-52.7 |
Shares Out. (M) |
142.99 |
|
EPS Est. Current Year |
-0.290 |
Return on Assets (ttm) |
-28.7 |
Shares Float (M) |
130.70 |
|
EPS Est. Next Year |
-0.240 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.40 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
-0.0 |
% Held by Institutions |
13.41 |
|
Forward EPS |
-0.140 |
Gross Profit (p.s.) |
-0.047 |
Shares Short (K) |
5340 |
|
Book Value (p.s.) |
0.210 |
EBITDA (p.s.) |
-0.101 |
P/E |
-5.06 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.18 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.38 |
P/S |
0.00 |
|
Operating Margin |
-16409.36 |
Levered Free Cash Flow
(M) |
-4.08 |
P/CF |
-9.20 |
|
|
|
|
|
|
